NEW YORK (GenomeWeb News) – Helicos BioSciences this week named Stephen Hall as its new CFO. Hall most recently served as CFO of TriPath Imaging, a publicly traded cancer diagnostics firm that was acquired by Becton Dickinson in December 2006.
 
He is a certified public accountant, and started his career at Peat, Marwick, Mitchell & Co. in Chicago. Hall has an AB from Harvard College and an MBA from Stanford University’s Graduate School of Business.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.